Agenus Inc (AGEN)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Agenus Inc Shines Bright: Impressive Revenue Surge Witnessed in Q3 2023
Agenus Inc Struggles to Weather Challenging Fiscal Quarter, Accumulates $251 Million Net Loss
Very decent performance by Agenus Inc in the fiscal three months ending December 31 2022
Extremely challenging reporting season for the company amid the third quarter of 2022